Oura IPO, Garmin EU Features, Amazfit Cheetah 2 Pro: June 2026 Roundup

Three stories landed this week that matter if you follow the wearables space seriously. Oura Health filed confidentially for a US IPO, with Goldman Sachs, Morgan Stanley, and JPMorgan running the deal. Paid membership quadrupled in two years, and their patent portfolio already pushed at least one rival out of the US market. That is real leverage going into a public offering.

The IPO timing is interesting because sports tech money is not infinite. Whoop went public earlier, Garmin is already listed, and Polar is still private. Oura is betting that its ring form factor and sleep-plus-readiness positioning gives it a lane that wrist-based optical heart rate devices like the Apple Watch Ultra 2 or Garmin Fenix 8 do not fully own. The ring captures blood volume pulse data continuously with less motion artifact than a wrist optical sensor during workouts. Whether public markets care about that nuance is another question.

On the Garmin side, EU regulators handed European users two iPhone features that Apple Watch owners have had for years: reply-from-wrist and Live Activities support, both arriving with iOS 26.5 pending a Garmin firmware update. US and UK accounts get nothing. This is a direct result of the EU Digital Markets Act forcing Apple to open APIs it kept locked. For a triathlete running a Garmin Fenix 8 or Forerunner 965 paired to an iPhone, replying to a message mid-ride without touching the phone is genuinely useful. The rest of the world keeps waiting.

The Amazfit Cheetah 2 Pro is the most substantive hardware news of the three. Titanium case, sapphire crystal, and a price hike of around 50 percent over the original Cheetah. Amazfit has not released a watch this serious in roughly three years. The review tested it against Garmin, Polar, and a Stryd foot pod as reference for running power, which is the right way to validate a running watch in 2026. GPS accuracy, optical heart rate via PPG, and pacing tools all matter here, but Stryd comparison data is the honest stress test.

Not a perfect week for any single product. Oura filing for IPO signals the ring category is maturing, the Garmin EU update shows regulatory pressure is reshaping the ecosystem, and Amazfit is back competing at a price point above budget. Worth watching all three.